{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:42:32Z","timestamp":1783539752261,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["K23 DK113252"],"award-info":[{"award-number":["K23 DK113252"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10620-019-05595-6","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T05:42:54Z","timestamp":1554356574000},"page":"2031-2038","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"64","author":[{"suffix":"Jr.","given":"Perry K.","family":"Pratt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle T.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A.","family":"Farraye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"5595_CR1","first-page":"15","volume":"Nov","author":"KO Chudy-Onwugaje","year":"2018","unstructured":"Chudy-Onwugaje KO, Christian KE, Farraye FA, Cross RK. A state-of-the-art review of new and emerging therapies for the treatment of IBD. Inflamm Bowel Dis. 2018;Nov:15.","journal-title":"Inflamm Bowel Dis"},{"key":"5595_CR2","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/ajg.2012.79","volume":"107","author":"JP Gisbert","year":"2012","unstructured":"Gisbert JP, Villagrasa JR, Rodr\u00edguez-Nogueiras A, et al. Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease. Am J Gastroenterol. 2012;107:1460\u20131466.","journal-title":"Am J Gastroenterol"},{"key":"5595_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1365-2036.2010.04570.x","volume":"33","author":"JP Gisbert","year":"2011","unstructured":"Gisbert JP, Chaparro M, Esteve M. Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33:619\u2013633.","journal-title":"Aliment Pharmacol Ther"},{"key":"5595_CR4","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1111\/jgh.13001","volume":"30","author":"P Andrade","year":"2015","unstructured":"Andrade P, Santos-Antunes J, Rodrigues S, et al. Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients. J Gastroenterol Hepatol. 2015;30:1591\u20131595.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"5595_CR5","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/MIB.0b013e31827febe9","volume":"19","author":"JP Gisbert","year":"2013","unstructured":"Gisbert JP, Villagrasa JR, Rodr\u00edguez-Nogueiras A, et al. Kinetics of anti-hepatitis B surface antigen titers after hepatitis B vaccination in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:554\u2013558.","journal-title":"Inflamm Bowel Dis"},{"key":"5595_CR6","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.cgh.2006.05.027","volume":"4","author":"AL Mindikoglu","year":"2006","unstructured":"Mindikoglu AL, Regev A, Schiff ER. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention. Clin Gastroenterol Hepatol. 2006;4:1076\u20131081.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5595_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jgh.12712","volume":"30","author":"Y Cossio-Gil","year":"2015","unstructured":"Cossio-Gil Y, Martinez-Gomez X, Campins-Marti M, et al. Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination. J Gastroenterol Hepatol. 2015;30:92\u201398.","journal-title":"J Gastroenterol Hepatol"},{"key":"5595_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ajg.2011.295","volume":"107","author":"J Moses","year":"2012","unstructured":"Moses J, Alkhouri N, Shannon A, et al. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab. Am J Gastroenterol. 2012;107:133\u2013138.","journal-title":"Am J Gastroenterol"},{"key":"5595_CR9","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s00535-015-1042-7","volume":"50","author":"H Matsumoto","year":"2015","unstructured":"Matsumoto H, Ohfuji S, Watanabe K, et al. Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial. J Gastroenterol. 2015;50:876\u2013886.","journal-title":"J Gastroenterol"},{"key":"5595_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00006454-199501000-00015","volume":"14","author":"SA Choudhury","year":"1995","unstructured":"Choudhury SA, Peters VB. Responses to hepatitis B vaccine boosters in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1995;14:65\u201367.","journal-title":"Pediatr Infect Dis J"},{"issue":"13","key":"5595_CR11","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S0264-410X(99)00389-8","volume":"18","author":"D Rey","year":"2000","unstructured":"Rey D, Krantz V, Partisani M, et al. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine. 2000;18:1161\u20131165.","journal-title":"Vaccine"},{"issue":"1","key":"5595_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","volume":"67","author":"S Schillie","year":"2018","unstructured":"Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2018;67:1\u201331.","journal-title":"MMWR Recomm Rep"},{"key":"5595_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/ajg.2016.537","volume":"112","author":"FA Farraye","year":"2017","unstructured":"Farraye FA, Melmed GY, Lichtenstein GR, et al. Preventative care in inflammatory bowel disease. Am J Gastroenterol. 2017;112:241\u2013258.","journal-title":"Am J Gastroenterol"},{"key":"5595_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/cid\/cit816","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:309\u2013318.","journal-title":"Clin Infect Dis"},{"key":"5595_CR15","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1086\/344271","volume":"35","author":"DN Fisman","year":"2002","unstructured":"Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis. 2002;35:1368\u20131375.","journal-title":"Clin Infect Dis"},{"key":"5595_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/ibd\/izx001","volume":"24","author":"PK Pratt","year":"2018","unstructured":"Pratt PK, Nunes D, Weber HC, et al. Antibody response to hepatitis B virus vaccine is impaired in patients with inflammatory bowel disease on infliximab therapy. Inflamm Bowel Dis. 2018;24:380\u2013386.","journal-title":"Inflamm Bowel Dis"},{"key":"5595_CR17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/00054725-200409000-00028","volume":"10","author":"BE Sands","year":"2004","unstructured":"Sands BE, Cuffari C, Katz JA, et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:677\u2013692.","journal-title":"Inflamm Bowel Dis"},{"key":"5595_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0749-3797(98)00003-8","volume":"15","author":"F Averhoff","year":"1998","unstructured":"Averhoff F, Mahoney F, Coleman P, et al. Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B infection. Am J Prev Med. 1998;15:1\u20138.","journal-title":"Am J Prev Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05595-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05595-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05595-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T14:20:45Z","timestamp":1589725245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05595-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["5595"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05595-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"11 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The other authors have no relevant conflicts to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}